Relationship Between the Circumference Difference and Findings of Indocyanine Green Lymphography in Breast Cancer-Related Lymphedema

被引:4
|
作者
Tokumoto, Hideki [1 ]
Akita, Shinsuke [2 ]
Kubota, Yoshitaka [2 ]
Mitsukawa, Nobuyuki [2 ]
机构
[1] Chiba Canc Ctr Hosp, Dept Plast & Reconstruct Surg, Chiba, Japan
[2] Chiba Univ, Dept Plast, Reconstruct & Aesthet Surg, Fac Med, Chiba, Chiba, Japan
关键词
breast cancer-related lymphedema; indocyanine green lymphography; circumference difference; partial part of the lymphedema; UPPER-EXTREMITY LYMPHEDEMA; ANASTOMOSIS; SEVERITY; SURGERY;
D O I
10.1097/SAP.0000000000002918
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Breast cancer-related lymphedema (BCRL) is a common complication. Indocyanine green (ICG) lymphography has been performed to assess lymphatic functionality. We found that some BCRL patients had a difference in circumference in partial regions only. The purpose of this study was to evaluate the patients with BCRL about the correlation between the difference in circumference and the findings of ICG lymphography. Methods One hundred fifty-five patients with unilateral BCRL were enrolled in this study. We evaluated the differences in circumference taken at 4 parts on the upper limb (at around the wrist, forearm, elbow, and brachium). The difference in circumference was evaluated between the affected part (C-af) and the unaffected part (C-un). We calculated the circumference difference rate (CDR) as follows: CDR = 100 (C-af - C-un)/C-af. First, we classified each part of all BCRL patients (620 parts) based on the findings of ICG lymphography (linear, collateral, dermal back flow [DBF], and no enhancement) and evaluated the correlation. Second, in the patients with partial volume change, we compared the mean CDR in each part. Results One hundred six parts were of a linear pattern, 31 parts were collateral, 350 parts were DBF, and 133 parts had no enhancement. The mean CDR of each finding was 3.3% in linear, 4.0% in collateral, 9.6% in DBF, and 9.4% in no enhancement. There was no significant difference between linear and collateral (P = 0.62), DBF, and no enhancement (P = 0.89) patterns. However, there was a significant difference between linear or collateral and DBF or no enhancement (all P < 0.001). In the 22 patients with distal DBF and proximal linear, the CDR was significantly higher in the forearm compared with the brachium (6.4% and 3.0%; P = 0.003). In the 26 patients with distal linear and proximal DBF, the CDR was significantly higher in the brachium compared with the forearm (4.3% and 7.7%; P = 0.005). Conclusions There was a significant correlation between the difference in circumference and the severity of ICG findings.
引用
收藏
页码:114 / 117
页数:4
相关论文
共 50 条
  • [31] ULTRASOUND ELASTOGRAPHY OF BREAST CANCER-RELATED LYMPHEDEMA
    Hashemi, H. S.
    Fallone, S.
    Boily, M.
    Towers, A.
    Kilgour, R. D.
    Rivaz, H.
    [J]. 2018 IEEE 15TH INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI 2018), 2018, : 1491 - 1495
  • [32] Guidelines on rehabilitation in breast cancer-related lymphedema
    Saul, M.
    Brito, C. M. M.
    Lourencao, M. I. P.
    Bazan, M.
    Otsubo, P.
    Imamura, M.
    Battistella, L. R.
    [J]. PROCEEDINGS OF THE 7TH WORLD CONGRESS OF INTERNATIONAL SOCIETY OF PHYSICAL AND REHABILITATION MEDICINE, 2013, : 252 - +
  • [33] Ultrasonography in the Evaluation of Breast Cancer-Related Lymphedema
    Rockson, Stanley G.
    [J]. LYMPHATIC RESEARCH AND BIOLOGY, 2016, 14 (01) : 1 - 1
  • [34] Hidden Costs in Breast Cancer-Related Lymphedema
    Martinez-Jaimez, Patricia
    Masia, Jaume
    Forero, Carlos G.
    Fuster, Pilar
    Monforte-Royo, Cristina
    [J]. SEMINARS IN ONCOLOGY NURSING, 2021, 37 (02)
  • [35] Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
    Jeon, Yumi
    Beom, Jaewon
    Ahn, Soyoung
    Bok, Soo-Kyung
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2017, (119):
  • [36] Breast Cancer-Related Lymphedema in Elderly Patients
    Balci, Fatih Levent
    DeGore, Lori
    Soran, Atilla
    [J]. TOPICS IN GERIATRIC REHABILITATION, 2012, 28 (04) : 243 - 253
  • [37] Growing Insights into Breast Cancer-Related Lymphedema
    Rockson, Stanley G.
    [J]. LYMPHATIC RESEARCH AND BIOLOGY, 2018, 16 (01) : 1 - 1
  • [38] Risk Factors of Breast Cancer-Related Lymphedema
    Ugur, Saadet
    Arici, Cumhur
    Yaprak, Muhittin
    Mesci, Ayhan
    Arici, Gulbin Ayse
    Dolay, Kemal
    Ozmen, Vahit
    [J]. LYMPHATIC RESEARCH AND BIOLOGY, 2013, 11 (02) : 72 - 75
  • [39] Doxycycline for the treatment of breast cancer-related lymphedema
    Brown, Stav
    Dayan, Joseph H.
    Coriddi, Michelle
    McGrath, Leslie
    Kataru, Raghu P.
    Mehrara, Babak J.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13